Search Results for: ITGB1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel EFNA4 ephrin A4
  • EPH-Ephrin signaling
  • EPH-Ephrin signaling
  • EPHA-mediated growth cone collapse
  • EPHA-mediated growth cone collapse
  • EPH-ephrin mediated repulsion of cells
  • EPH-ephrin mediated repulsion of cells
Novel TGFBR1 transforming growth factor beta receptor 1
  • Downregulation of TGF-beta receptor signaling
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • TGFBR1 KD Mutants in Cancer
  • TGFBR1 LBD Mutants in Cancer
  • UCH proteinases
  • Ub-specific processing proteases
  • 4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline
  • Naphthyridine Inhibitor
  • 3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole
  • N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide
  • 2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine
  • N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine
  • Fostamatinib
  • Loeys-Dietz syndrome (LDS)
  • Familial thoracic aortic aneurysm and dissection (TAAD); Aortic aneurysm familial thoracic type (AAT)
Novel TNC tenascin C
  • Integrin cell surface interactions
  • Syndecan interactions
  • ECM proteoglycans
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
Novel ZEB1 zinc finger E-box binding homeobox 1
  • Interleukin-4 and Interleukin-13 signaling
  • Posterior polymorphous corneal dystrophy (PPCD)
  • Fuchs corneal dystrophy (FECD); Fuchs endothelial corneal dystrophy
Novel ZNF33A zinc finger protein 33A
  • Generic Transcription Pathway
ACAP1 ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
ACTN1 actinin alpha 1
  • Platelet degranulation
  • Syndecan interactions
  • Nephrin family interactions
  • Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
  • Human calcitonin
  • Copper
ACTN4 actinin alpha 4
  • Platelet degranulation
  • Nephrin family interactions
  • Nephrotic syndrome and focal segmental glomerulosclerosis
ARHGAP5 Rho GTPase activating protein 5
  • Rho GTPase cycle
CANX calnexin
  • Assembly of Viral Components at the Budding Site
  • MHC class II antigen presentation
  • Interleukin-35 Signalling
  • Calnexin/calreticulin cycle
  • Interleukin-27 signaling
  • Maturation of spike protein
  • Maturation of spike protein
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Antihemophilic factor, human recombinant
  • Tenecteplase
  • Lanoteplase
  • Calcium citrate
  • Calcium Phosphate
  • Lonoctocog alfa
  • Moroctocog alfa
  • Calcium phosphate dihydrate
CD151 CD151 molecule (Raph blood group)
  • Assembly of collagen fibrils and other multimeric structures
  • Type I hemidesmosome assembly
  • Nephropathy with pretibial epidermolysis bullosa and deafness
CD36 CD36 molecule
  • Platelet degranulation
  • Cross-presentation of particulate exogenous antigens (phagosomes)
  • ER-Phagosome pathway
  • MyD88:MAL(TIRAP) cascade initiated on plasma membrane
  • Toll Like Receptor TLR6:TLR2 Cascade
  • PPARA activates gene expression
  • Scavenging by Class B Receptors
  • Scavenging by Class B Receptors
  • Transcriptional regulation of white adipocyte differentiation
  • Intracellular metabolism of fatty acids regulates insulin secretion
  • MyD88 deficiency (TLR2/4)
  • IRAK4 deficiency (TLR2/4)
  • Regulation of TLR by endogenous ligand
  • Interleukin-4 and Interleukin-13 signaling
  • Neutrophil degranulation
CD46 CD46 molecule
  • Regulation of Complement cascade
CD82 CD82 molecule
CD9 CD9 molecule
  • Platelet degranulation
  • Acrosome Reaction and Sperm:Oocyte Membrane Binding
  • Uptake and function of diphtheria toxin
  • C31G
CRKL CRK like proto-oncogene, adaptor protein
  • Frs2-mediated activation
  • Frs2-mediated activation
  • Downstream signal transduction
  • MET activates RAP1 and RAC1
  • MET receptor recycling
  • Erythropoietin activates RAS
  • Erythropoietin activates RAS
  • Regulation of signaling by CBL
DAG1 dystroglycan 1
  • Non-integrin membrane-ECM interactions
  • ECM proteoglycans
  • ECM proteoglycans
  • Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3
  • Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2
  • Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1
  • O-linked glycosylation
  • Regulation of expression of SLITs and ROBOs
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
  • Limb-girdle muscular dystrophy (LGMD)
DOK1 docking protein 1
  • PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
  • RET signaling
EGFR epidermal growth factor receptor
  • Signaling by ERBB2
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Signaling by ERBB4
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • PLCG1 events in ERBB2 signaling
  • PIP3 activates AKT signaling
  • Signaling by EGFR
  • GRB2 events in EGFR signaling
  • GAB1 signalosome
  • SHC1 events in EGFR signaling
  • EGFR downregulation
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • EGFR interacts with phospholipase C-gamma
  • EGFR Transactivation by Gastrin
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Signal transduction by L1
  • Constitutive Signaling by EGFRvIII
  • Inhibition of Signaling by Overexpressed EGFR
  • RAF/MAP kinase cascade
  • ERBB2 Regulates Cell Motility
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • ERBB2 Activates PTK6 Signaling
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • PTK6 promotes HIF1A stabilization
  • Downregulation of ERBB2 signaling
  • TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
  • Extra-nuclear estrogen signaling
  • NOTCH3 Activation and Transmission of Signal to the Nucleus
  • HCMV Early Events
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • Cetuximab
  • Lidocaine
  • Gefitinib
  • Erlotinib
  • Lapatinib
  • Panitumumab
  • Alvocidib
  • IGN311
  • Matuzumab
  • Vandetanib
  • Rindopepimut
  • Canertinib
  • Pelitinib
  • Varlitinib
  • AV-412
  • S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
  • PD-168393
  • Afatinib
  • Osimertinib
  • Necitumumab
  • Foreskin keratinocyte (neonatal)
  • Depatuxizumab mafodotin
  • Icotinib
  • Neratinib
  • Dacomitinib
  • Fostamatinib
  • Zalutumumab
  • Brigatinib
  • Olmutinib
  • Zanubrutinib
  • Abivertinib
  • Choriocarcinoma
  • Gastric cancer
  • Bladder cancer
  • Oral cancer
  • Glioma
  • Laryngeal cancer
  • Cervical cancer
  • Esophageal cancer
ENO1 enolase 1
  • Glycolysis
  • Gluconeogenesis
  • Manipulation of host energy metabolism
  • Zinc
  • Copper
  • Artenimol
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form

Page 1 out of 5 pages